With over 2 million people in the United States alone known to abuse opioid-based pain medications, addiction to these drugs represents a significant public health concern. The mu-opioid receptor (MOR) is the member of the G protein-coupled receptor (GPCR) family that primarily mediates the actions of clinically used opioid- based analgesics. Based on extensive in vitro and in vivo work over the past decades, it has become increasingly clear that opioid ligands can produce different signaling, phosphorylation, desensitization, and internalization of MOR, with major implications for its physiological responses, including the development of analgesic tolerance. The recent suggestion that MOR oligomerization can modulate receptor binding, signaling, and/or trafficking further complicates our understanding of MOR-mediated function. The overall goal of the research proposed in this application is to reveal the molecular mechanisms underlying the observed functional selectivity at MOR. This information is important to ensure the fine-tuning of MOR signaling towards desired therapeutic pathways but away from those mediating adverse side effects, with the ultimate goal of discovering non-addictive analgesic agents. The computational research proposed in this grant application takes advantage of cutting-edge developments in theory and experiments to obtain rigorous mechanistic insight, at an unprecedented level of molecular detail, into the structure, spatio-temporal organization, and dynamics of MOR in the membrane, thus broadening current understanding of MOR biased agonism. Specifically, we will contribute structural and dynamic information regarding sparsely-populated states of MOR that are currently impossible or difficult to retrieve experimentally, thereby generating testable hypotheses of how, at the molecular level, different opioids induce differential oligomerization and signaling of MOR, leading to the specific behavioral effects of the drugs. Experimental validation of these computational predictions, to be attained through collaborations with independently funded laboratories, will advance our current understanding of fundamental basic mechanisms of MOR function, and pave the way to novel therapeutic strategies against drug abuse and addiction. The data that will emerge from this application will be added to other relevant recent information on GPCR oligomerization, and further populate our recently deployed GPCR-Oligomerization Knowledge Base system to continue to promote and support productive collaborations between computational and experimental scientists working on GPCRs involved in drug abuse.

Public Health Relevance

The goal of our research is to understand the molecular mechanisms underlying the diverse physiological functions of mu-opioid receptors to ultimately develop analgesics that are free from side effects.

National Institute of Health (NIH)
National Institute on Drug Abuse (NIDA)
Research Project (R01)
Project #
Application #
Study Section
Molecular Neuropharmacology and Signaling Study Section (MNPS)
Program Officer
Hillery, Paul
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Icahn School of Medicine at Mount Sinai
Schools of Medicine
New York
United States
Zip Code
Ferré, Sergi; Casadó, Vicent; Devi, Lakshmi A et al. (2014) G protein-coupled receptor oligomerization revisited: functional and pharmacological perspectives. Pharmacol Rev 66:413-34
Johnston, Jennifer M; Filizola, Marta (2014) Beyond standard molecular dynamics: investigating the molecular mechanisms of G protein-coupled receptors with enhanced molecular dynamics methods. Adv Exp Med Biol 796:95-125
Johnston, Jennifer M; Filizola, Marta (2014) Differential stability of the crystallographic interfaces of mu- and kappa-opioid receptors. PLoS One 9:e90694
Shang, Yi; LeRouzic, Valerie; Schneider, Sebastian et al. (2014) Mechanistic insights into the allosteric modulation of opioid receptors by sodium ions. Biochemistry 53:5140-9
Filizola, Marta; Devi, Lakshmi A (2013) Grand opening of structure-guided design for novel opioids. Trends Pharmacol Sci 34:6-12
Negri, Ana; Rives, Marie-Laure; Caspers, Michael J et al. (2013) Discovery of a novel selective kappa-opioid receptor agonist using crystal structure-based virtual screening. J Chem Inf Model 53:521-6
Scarabelli, Guido; Provasi, Davide; Negri, Ana et al. (2013) Bioactive conformations of two seminal delta opioid receptor penta-peptides inferred from free-energy profiles. Biopolymers :
Gomes, Ivone; Fujita, Wakako; Gupta, Achla et al. (2013) Identification of a *-ýý opioid receptor heteromer-biased agonist with antinociceptive activity. Proc Natl Acad Sci U S A 110:12072-7
Mondal, Sayan; Johnston, Jennifer M; Wang, Hao et al. (2013) Membrane driven spatial organization of GPCRs. Sci Rep 3:2909